Xue-Ran Guo
Overview
Explore the profile of Xue-Ran Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia M, Liu K, Zhao W, Cheng Y, Shi L, Bi L, et al.
Brachytherapy
. 2025 Jan;
24(1):92-102.
PMID: 39818422
Purpose: To compare the effectiveness and safety of CT-guided iodine-125 seed brachytherapy in conjunction with chemotherapy against chemotherapy alone for the management of intermediate and advanced non-small cell lung cancer...
2.
Zhang J, Xiong H, Cao J, Wang S, Guo X, Lin B, et al.
Theranostics
. 2022 Jun;
12(8):3601.
PMID: 35664069
[This corrects the article DOI: 10.7150/thno.20047.].
3.
Zhang T, Guo X, Wu Y, Kang X, Zheng Q, Qi R, et al.
Gut
. 2019 Mar;
69(2):343-354.
PMID: 30926653
Objective: This study aimed to develop a novel therapeutic vaccine based on a unique B cell epitope and investigate its therapeutic potential against chronic hepatitis B (CHB) in animal models....
4.
Kang X, Guo X, Chen B, Zhang T, Yuan Q, Chen P, et al.
Hum Vaccin Immunother
. 2018 Mar;
14(7):1779-1781.
PMID: 29533134
No abstract available.
5.
Zhang J, Xiong H, Cao J, Wang S, Guo X, Lin B, et al.
Theranostics
. 2018 Jan;
8(2):549-562.
PMID: 29290826
Monoclonal antibodies (mAbs) mostly targeting extracellular or cell surface molecules have been widely used in the treatment of various diseases. However, mAbs cannot pass through the cell membrane as efficiently...
6.
Zhang T, Yuan Q, Zhao J, Zhang Y, Yuan L, Lan Y, et al.
Gut
. 2015 Oct;
65(4):658-71.
PMID: 26423112
Objective: This study aimed to investigate the therapeutic potential of monoclonal antibody (mAb) against HBV as a novel treatment approach to chronic hepatitis B (CHB) in mouse models. Methods: Therapeutic...